SPOTLIGHT -
Scariest in Psychiatry
What scares mental health clinicians? We asked, and these brave individuals replied…
Decriminalizing Mental Health: Partnering With Law Enforcement to Reduce Unwanted Outcomes
How can PMHNP consults with law enforcement reduce involuntary transfers and other unwanted outcomes?
App Intervention May Reduce Insomnia in Health Care Workers
Does the YOI intervention improve mental health workers’ insomnia? Research says yes.
ADHD Drugs Negatively Affect Bone Density
Recent research determined the medications modafinil, atomoxetine, and guanfacine negatively impact bones.
Psychiatric Times™ Conference: Clinical Pearls, New Research
Did you miss the 2022 Annual Psychiatric Times™ World CME Conference? We've got you covered.
Understanding the Long-Term Clinical Course of Comorbid SUD and ADHD
Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?
New Poll Data Shows US Adults Believe Suicide Can be Prevented
A new poll sought to understand the public’s beliefs about mental health and suicide prevention. Here are the results.
Advocating for Medication for Opioid Use Disorder
The NCCHC and 166 national organizations recently signed a letter to Senate leadership advocating for increased access to buprenorphine.
USPSTF Makes Historic Anxiety and Depression Draft Screening Recommendations
For the first time, the USPSTF is recommending anxiety screening for adults under 65.
Reading First-Hand Stories May Help Reduce Suicidal Thoughts
Reading 1 story a day might help those living with suicidal thoughts and behaviors.
NDA for Long-Acting Injectable for Schizophrenia and Bipolar I Accepted
The FDA has accepted the NDA for aripiprazole 2-month, ready-to-use, long-acting injectable.
Stimulant-Induced Persistent Psychotic Disorder: New Treatment Potential
Long-acting injectable haloperidol decanoate may work as a treatment for Adderall-induced persistent psychosis.
Mood Shifts Have Opposite Impact on Alcohol Cravings in Men and Women
A new study finds mood shifts and alcohol-related cues affect men and women differently in terms of alcohol cravings.
New Position Statement on Trauma-Responsive Care for Youth
The National Commission on Correctional Health Care has issued a new directive for trauma-responsive care for children and adolescents in correctional facilities.
The Role of Alcohol and Substances in Suicide
Suicide Prevention Week is September 4-10. Are you ready?
The Overdose Epidemic and the “Astounding” Life Expectancy Drop
New data shows a decrease in life expectancy in the United States. Here’s why.
Psychedelics for the Treatment of Binge Eating Disorder in Males
This new study is evaluating how effective psychedelics can be in the treatment of binge eating disorder.
First Patient Dosed in Trial of LSD for Generalized Anxiety Disorder
The first patient has been dosed in the phase 2b dose-optimization trial of a pharmaceutically optimized form of LSD for the treatment of generalized anxiety disorder.
The Recent Resurgence of Psilocybin: Is It Here to Stay?
One researcher shares his evidence for the usage of psilocybin in psychiatry.
Novel Oral NMDA Receptor Antagonist Approved for Treatment of MDD
Dextromethorphan HBr -bupropion HCl extended-release tablets for the treatment of major depressive disorder just became FDA approved.
COVID-19: A Direct Viral Attack on the Brain
What are the long term psychiatric and neuropsychiatric complications of COVID-19?
The Importance of Managing Psychiatric Disorders During Pregnancy and Postpartum
Treating women of reproductive age who have depression can be difficult. Here’s an overview on the subject from the 2022 Annual Psychiatric Times™ World CME Conference.
Trauma in Your DNA: Educator of the Year Lecture
Can we inherit our parents’ trauma? Research points to yes.
Childhood Trauma: 10 Tips for Screening and More
How do you screen for childhood trauma? One doctor at the 2022 Annual Psychiatric Times™ World CME Conference in San Diego, one doctor shared his most helpful tips.
Caution Ahead: FDA Asks for More Info on Expanded Use of Antipsychotic Drug
Alzheimer disease psychosis treatment pimavanserin receives Complete Response Letter from the FDA.
“A New and Differentiated Approach for Schizophrenia”: Positive Results for Phase 3 Trial
This novel schizophrenia treatment showed positive results in a phase 3 trial evaluating efficacy, safety, and tolerability.
New Review Calls Antidepressants Into Question—But Does the Review Have Merit?
A new review shows that there is no convincing evidence that depression is caused low levels of serotonin.
Loan Repayment Program to Help Ease Student Debt Burden for Psychiatrists
Do you qualify for student loan forgiveness?
Reducing Heavy Drinking Days: Positive Results From Trial for Medication Treating Alcohol Use Disorder
Positive results from the phase 3 trial of AD04 show a 79% reduction in heavy drinking.
Upcoming Release of Phase 3 Trial Results for Medication Treating Alcohol Use Disorder
New results are coming for AD04, a potential treatment for patients with alcohol use disorder.